EuBiologics Co., Ltd. (KOSDAQ:206650)
South Korea · Delayed Price · Currency is KRW 9,110.00
-400.00 (-4.21%)
Aug 31, 2026, 3:30 PM KST
EuBiologics Market Cap
EuBiologics has a market cap or net worth of 349.51 billion as of August 31, 2026. Its market cap has decreased by -29.83% in one year.
Market Cap
349.51B
Enterprise Value
n/a
Revenue
96.04B
Ranking
n/a
PE Ratio
14.06
Stock Price
9,110.00
ChartMarket Cap Chart
Since January 24, 2017, EuBiologics's market cap has increased from 122.86B to 349.51B, an increase of 184.49%. That is a compound annual growth rate of 11.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 334.81B | -19.63% |
| Dec 30, 2025 | 416.60B | -6.15% |
| Dec 30, 2024 | 443.89B | 6.16% |
| Dec 28, 2023 | 418.14B | 28.91% |
| Dec 29, 2022 | 324.36B | -74.49% |
| Dec 30, 2021 | 1.27T | 93.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 24, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shinpoong Pharmaceutical Co.,Ltd | 521.42B |
| Ildong Pharmaceutical | 467.58B |
| Bukwang Pharmaceutical | 414.39B |
| Dong-A ST | 368.68B |
| JW Holdings | 286.45B |
| Humedix | 270.90B |
| Huons | 258.67B |
| Korea United Pharm | 255.22B |